AOD9604 Peptide – 5MG

AOD‑9604  5 mg | High‑Purity hGH‑Derived Research Peptide | Research Use Only

AOD‑9604 is a specialised peptide fragment derived from the C‑terminal region of human growth hormone (hGH), supplied for controlled in‑vitro peptide pharmacology, receptor‑adjacent signalling studies, and structure–activity relationship (SAR) investigations. Provided as a 5 mg lyophilised vial for laboratory research only. Not for human use.

What is AOD‑9604?

AOD‑9604 is an hGH‑fragment analogue widely used in peptide‑based mechanistic studies. Researchers utilise AOD‑9604 to investigate:

• hGH‑adjacent signalling pathways
• Peptide pharmacology and SAR profiling
• Downstream second‑messenger responses
• Controlled biochemical and cell‑based assay development

All applications are restricted to non‑clinical, in‑vitro laboratory environments.

Key Features

• hGH‑derived peptide fragment for advanced signalling and SAR research
• Supplied as a stable lyophilised solid for reliable storage
• Unit size: 5 mg per vial
• Each batch undergoes strict internal QC for identity, purity, and appearance
• Provided strictly for laboratory research — not for human or veterinary use

Specifications

• Product name: AOD‑9604
• Synonyms: hGH fragment analogue; C‑terminal hGH peptide
• Class: Peptide fragment/analogue (research use)
• Form: Lyophilised powder
• Appearance: White to off‑white solid
• Note: Salt form, counter‑ion, and hydration state may vary by lot. Refer to vial label for batch‑specific details.

Handling & Storage

• Dry storage: Store vials at 2–8 °C, protected from light and moisture
• Reconstitution: Follow laboratory SOPs for solvent selection and assay compatibility
• After reconstitution: Store at 2–8 °C, protect from light, use aliquots, and avoid repeated freeze–thaw cycles
• Compatibility: Use only within validated research protocols aligned with institutional SOPs and local regulations

Research Applications

AOD‑9604 is used in controlled in‑vitro systems to investigate:

• Peptide fragment analogues
• GH‑axis signalling pathways
• Second‑messenger responses
• Comparative SAR profiling

All studies occur exclusively in non‑clinical laboratory environments.

Certificate of Analysis (COA)

Each lot of AOD‑9604 undergoes internal QC checks for identity, purity, and appearance before release. COA available upon request for qualified research institutions.

Synthesis & Quality Assurance

AOD‑9604 is manufactured through validated peptide‑synthesis processes designed for:

• High purity
• Lot‑to‑lot consistency
• Reliable performance in biochemical and cell‑based assays

Every batch is reviewed under strict internal quality standards.

Related Research Materials

• HGH‑Frag (176–191) 5 mg
• CJC‑1295 (No DAC) 5 mg
• Ipamorelin 5 mg

Why Choose Pep Lab London?

• ISO‑aligned internal QC
• Clinical‑white branding and transparent sourcing
• Research‑only compliance
• Fast UK shipping
• Trusted by GH‑axis and peptide‑mechanistic research labs

Legal & Safety Notice

Pep Lab London supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics, and must not be used in humans or animals. By purchasing, you confirm you are a qualified researcher and will handle the material according to institutional policies and applicable regulations.

Disclaimer

This material is intended solely for in‑vitro research and cannot be:

• Used in clinical studies involving humans
• Administered to humans in any form
• Supplied to any party for human investigational use